Banque Cantonale Vaudoise’s ChemoCentryx, Inc. CCXI Stock Holding History

Banque Cantonale Vaudoise’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-856	Closed	-$21K	–	1312
2022 Q2	$21K	Buy	856 +73	+9%	+$1.61K	﹤0.01%	1133
2022 Q1	$20K	Sell	783 -1,548	-66%	-$43.5K	﹤0.01%	1153
2021 Q4	$85K	Sell	2,331 -174	-7%	-$6.11K	﹤0.01%	989
2021 Q3	$43K	Sell	2,505 -85	-3%	-$1.32K	﹤0.01%	1076
2021 Q2	$35K	Hold	2,590	–	–	﹤0.01%	1096
2021 Q1	$133K	Sell	2,590 -52	-2%	-$3.13K	0.01%	857
2020 Q4	$164K	Sell	2,642 -63	-2%	-$3.61K	0.01%	770
2020 Q3	$148K	Buy	2,705 +9	+0.3%	+$485	0.01%	761
2020 Q2	$155K	Sell	2,696 -86	-3%	-$4.68K	0.01%	715
2020 Q1	$112K	Buy	+2,782	New	+$118K	0.01%	745

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Banque Cantonale Vaudoise's CCXI Position: Q3 2022 in Review

Banque Cantonale Vaudoise sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 856 shares — an estimated $21K sold.

Banque Cantonale Vaudoise first reported a position in CCXI in Q1 2020 and held it in 10 quarters. The position peaked at $164K in Q4 2020. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Banque Cantonale Vaudoise reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Banque Cantonale Vaudoise sold 856 ChemoCentryx, Inc. shares in Q3 2022, an estimated $21K.
Banque Cantonale Vaudoise first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 10 quarters.
Banque Cantonale Vaudoise's ChemoCentryx, Inc. position peaked at $164K in Q4 2020.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2022, filed 17 Oct 2022.